These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9123887)

  • 1. [Anti-HIV chemotherapy targeted at host-cellular factors].
    Baba M
    Uirusu; 1996 Dec; 46(2):155-60. PubMed ID: 9123887
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin E and alpha-lipoate: role in antioxidant recycling and activation of the NF-kappa B transcription factor.
    Packer L; Suzuki YJ
    Mol Aspects Med; 1993; 14(3):229-39. PubMed ID: 8264337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors].
    Yu MY; Liu XY
    Yao Xue Xue Bao; 2007 Oct; 42(10):1007-12. PubMed ID: 18229603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-kappa B-independent mechanism.
    Vlach J; Pitha PM
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2401-8. PubMed ID: 8245855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy.
    Victoriano AF; Okamoto T
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):125-38. PubMed ID: 22077140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
    Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism.
    Okamoto T; Ogiwara H; Hayashi T; Mitsui A; Kawabe T; Yodoi J
    Int Immunol; 1992 Jul; 4(7):811-9. PubMed ID: 1498089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forcing the enemy to come out and surrender: a strategy for an AIDS cure.
    Al-Jabri AA
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):45-6. PubMed ID: 25456568
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs.
    Bednarik DP; Duckett C; Kim SU; Perez VL; Griffis K; Guenthner PC; Folks TM
    New Biol; 1991 Oct; 3(10):969-76. PubMed ID: 1768651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A.
    Tietjen I; Williams DE; Read S; Kuang XT; Mwimanzi P; Wilhelm E; Markle T; Kinloch NN; Naphen CN; Tenney K; Mesplède T; Wainberg MA; Crews P; Bell B; Andersen RJ; Brumme ZL; Brockman MA
    Antiviral Res; 2018 Apr; 152():94-103. PubMed ID: 29476895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB.
    Klebanoff SJ; Watts DH; Mehlin C; Headley CM
    J Infect Dis; 1999 Mar; 179(3):653-60. PubMed ID: 9952372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
    J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-resistant variants of HIV-1 in lung.
    Gates A; Coker R; Miller R; Mitchell D; Williamson J; Clarke J
    AIDS; 1997 Apr; 11(5):702-3. PubMed ID: 9108966
    [No Abstract]   [Full Text] [Related]  

  • 16. Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif.
    Faure E; Rameil P; Lecine P; Rey F; Sire J; Kahn-Perles B; Imbert J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):353-65. PubMed ID: 9519897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
    Doppler C; Schalasta G; Amtmann E; Sauer G
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and alcohol use: consequences of comorbidity.
    Bean P
    Am Clin Lab; 2001 Aug; 20(7):13-6. PubMed ID: 11570268
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy.
    Pande V; Ramos MJ
    Curr Med Chem; 2003 Aug; 10(16):1603-15. PubMed ID: 12871131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.